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Background: Simultaneous use of cell-permeant and impermeant fluorescent nuclear dyes is a common method
to study cell viability and cell death progression. Although these assays are usually conducted as end-point studies,
time-lapse imaging offers a powerful technique to distinguish temporal changes in cell viability at single-cell
resolution. SYTO 13 and Hoechst 33342 are two commonly used cell-permeant nuclear dyes; however their
suitability for live imaging has not been well characterized. We compare end-point assays with time-lapse imaging
studies over a 6 h period to evaluate the compatibility of these two dyes with longitudinal imaging, using both
control neurons and an apoptotic neuron model.
Findings: In longitudinal assays of untreated neurons, SYTO 13 addition caused acute necrosis within 3 h, whereas
neurons imaged with Hoechst remained viable for at least 6 h. In a staurosporine-induced apoptotic model of
neurotoxicity, determinations of the mode of cell death and measurements of nuclear size were identical between
longitudinal studies using Hoechst and end-point assays. Alternatively, longitudinal studies using 500 nM or 5 nM
SYTO 13 were not consistent with end-point assays.
Conclusions: SYTO 13 is acutely neurotoxic and when used in longitudinal studies, masked end-stage morphologic
evidence of apoptotic cell death. In contrast, a single application of Hoechst evoked no evidence of toxicity over a
6 h period, and was consistent with end-point characterizations of cell viability and nuclear morphology. For
longitudinal characterization of acute cell death, Hoechst is a superior option.
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Background
The paired use of fluorescent membrane-permeant and
impermeant nuclear dyes is an established method of
evaluating morphological changes associated with end-
stage cell death [1]. These dyes undergo a large fluores-
cent enhancement upon binding nucleic acids and, in
conjunction with imaging methods such as flow cytome-
try or fluorescent microscopy, enable facile, rapid and
quantitative discrimination between the classical ter-
minal sequelae of apoptosis (condensed nuclei, intact
membrane) and necrosis (normal or swollen nuclei,
permeabilized plasma membrane) [2,3]. Cell-permeant* Correspondence: patrick.mcnutt@us.army.mil
United States Army Medical Research Institute of Chemical Defense, 3100
Ricketts Point Rd, Aberdeen Proving Ground, MD 21010, USA
© 2012 Hubbard et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the ornuclear markers such as SYTO 13 or Hoechst 33342
(Hoechst) provide information about nuclear morph-
ology, while cells with disrupted plasma membranes are
marked by nuclear uptake of cell-impermeant dyes such
as propidium iodide (PI).
Nuclear markers are typically used in end-point assays
to discriminate among viable, necrosed or apoptosed
cells. When used in conjunction with live imaging, these
dyes have the potential to enable longitudinal
characterization of the onset of cell death with single-
cell resolution. The statistical comparison of cell behav-
ior using repeated measures over time allows for
increased power and sensitivity compared to end-point
assays, particularly in populations in which cell death
occurs by multiple mechanisms. However, since acute
cytotoxicity would confound interpretations of cell via-
bility, membrane-permeant nuclear dyes have to beal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suitability of SYTO 13 and Hoechst for longitudinal im-
aging of neuron viability and identification of modes of
end-stage cell death over a 6 h window.
Baseline studies suggest SYTO 13 is incompatible with
longitudinal cell viability
In an attempt to develop a longitudinal assay of neuron
viability, we evaluated nuclear morphology and plasma
membrane integrity over a 6 h period after administration
of 8 μM Hoechst or 500 nM SYTO 13. Unlike SYTO 13,
which required hourly application, a single administration
of Hoechst was sufficient to visualize nuclei throughout
the 6 h experiment. Viable neurons were initially PI-nega-
tive, with nuclei that were 9.1 ± 0.66 μm in diameter.
Whereas neurons exposed to Hoechst remained PI-
negative through 6 h, neurons treated with SYTO 13
exhibited PI uptake within 3 h (Figure 1A). Neither dye
elicited a significant change in nuclear size (Figure 1B).
The co-localization of Hoechst and PI in neurons with
disrupted membranes resulted in a purple hue (top
panels), whereas the PI fluorescence overwhelmed SYTO
13 (bottom panel) unless the green channel gain was
increased beyond the dynamic range (not shown). Con-
densed, PI-positive nuclei (purple in top panels, red in
bottom panels) present at time 0 represent cells that
underwent primary apoptosis during initial plating fol-
lowed by secondary necrosis, a common phenomenon
with in vitro models [4].
Longitudinal use of SYTO 13 alters neuron cell death in a
model of apoptosis
The above experiments suggested that SYTO 13 was
acutely neurotoxic. To determine whether the presump-
tive toxicity associated with SYTO 13 interfered with
morphological determination of apoptotic cell death, we
evaluated nuclear morphology and plasma membraneFigure 1 Neurons visualized with SYTO 13 or Hoechst exhibit differen
with Hoescht (blue) remained viable over 6 h. Neurons stained with SYTO
White arrows indicate cells that became PI-positive in each frame. (B) Repe
regardless of PI uptake.integrity among neurons treated with the pro-apoptotic
kinase inhibitor staurosporine [5]. Neuron fate was com-
pared between end-point assays conducted 6 h after
staurosporine addition and longitudinal assays, in which
nuclear morphologies were imaged every hour for 6 h
using PI with either SYTO 13 or Hoechst uptake.
In end-point assays conducted 6 h after staurosporine
addition, neurons had PI-negative, condensed nuclei that
were 35.0 ± 5.1% (Hoechst) or 37.3 ± 7.4% (SYTO 13) the
area of untreated controls (Figure 2; P < 0.001 for both
dyes). In longitudinal imaging using Hoechst, nuclear
condensation was visually apparent by 4 h, with PI-
negative nuclei at 6 h that were 41.1 ± 6.4% of the area
measured at 0 h (Figure 3; P < 0.001). In contrast, SYTO
13-stained neurons were PI-positive by 2 h, without evi-
dence of nuclear condensation through 6 h (Figure 3).
As in Figure 1, the PI signal overwhelmed the SYTO 13
signal at 500 nM.
These data unambiguously demonstrate that neurons
exposed to repeated doses of 500 nM SYTO 13 under-
went acute necrosis, even when exposed to apoptotic
stimuli. Reasoning that SYTO 13 neurotoxicity may be
dose-dependent, neurons were evaluated by time-lapse
imaging using 5 nM SYTO 13. The lower concentration
of SYTO 13 eliminated PI uptake in staurosporine-
treated neurons throughout 6 h (Figure 3A). Nuclear
diameters were difficult to measure because of diffuse
nuclear staining; however, at the lower SYTO 13 dose
nuclear areas were only reduced to 74.7 ± 12.9% relative
to 0 h (Figure 3B).
Discussion
Defining the molecular and biochemical pathways re-
sponsible for cell death phenotypes is essential for iden-
tifying critical points that could be exploited to prevent,
delay or re-direct cell death mechanisms. This requires
the ability to conduct time-lapse characterization oft outcomes during time-lapse microscopy. (A) Neurons visualized
13 (green) became PI-positive by 6 h, indicative of necrotic cell death.
ated measures quantitation of nuclear area demonstrated no changes
Figure 2 End-point assays of control and staurosporine-treated neurons exhibit identical outcomes at 6 h. (A) End-point characterization
of nuclear morphology 6 h after addition of vehicle (top panels) or staurosporine (bottom panels). Neurons were visualized using PI plus either
Hoescht (blue) or SYTO 13 (green). Note that neither vehicle nor staurosporine addition caused necrotic cell death. (B) Planimetric measurements
of nuclear size. * represent p < 0.01.
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death. However, a longitudinal assay to visualize the
morphologic alterations associated with cell death has
not been well-described. Here we demonstrate that
SYTO 13 is acutely neurotoxic in vitro, whereas Hoescht-
treated neurons do not exhibit symptoms of toxicity over
a 6 h period. Thus for short-term longitudinal imaging of
viability and morphologic characterization of apoptotic
cell death Hoechst is the preferred dye.
Despite manufacturer warnings that SYTO 13 is not
recommended for imaging nuclear morphology, a num-
ber of publications have used SYTO 13 to evaluate nu-
clear changes associated with cell death phenotypes, inFigure 3 Staurosporine-treated neurons undergo different outcomes
Neurons stained with Hoescht (blue; top panels) visually undergo chromati
neurons visualized with 500 or 5 nM SYTO 13 (green) became PI-positive (r
arrows indicate cells that became PI-positive in each frame. Condensed, PI-
observed at time 0 represent cells that died during initial plating. In bottom
resulted in PI-positive nuclei developing an orange hue. (B) Planimetric qua
experiment. * represent p < 0.05; ^ represents p < 0.01.some cases during longitudinal cell viability assays [6-9].
Here we demonstrate that 500 nM SYTO 13 elicited
acute necrosis and prevented staurosporine-induced
chromatin condensation in time-lapse imaging studies.
Reduction of SYTO 13 to 5 nM prevented acute
necrosis, but resulted in less intense nuclear staining
and an intermediate degree of nuclear condensation
compared to end-point studies. In contrast, control
neurons longitudinally imaged with Hoechst exhibited
no morphological evidence of neurotoxicity over 6 h,
and underwent a similar degree of chromatin condensa-
tion following staurosporine treatment as in end-point
studies.when SYTO 13 and Hoechst are used in time-lapse imaging. (A)
n condensation within 4 h and remained PI-negative. In contrast,
ed) by 2 h, without visual evidence of chromatin condensation. White
positive nuclei (purple in top panels, red in middle and bottom panels)
panels, the increased gain needed to clearly image nuclear structure
ntitation of nuclear size measured longitudinally through the 6 h
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described here is unclear, but could be a consequence of
nuclear binding or interaction with cytoplasmic nucleic
acids. Regardless of the mechanism, the end-stage cell
death markers of necrosis were observed prior to those of
apoptosis, suggesting that acute neurotoxicity interferes
with apoptotic progression. There are several possible
explanations for the intermediate degree of chromatin
condensation observed with the lower dose of SYTO 13.
For example, injury mechanisms may be initiated that do
not result in overt necrosis by 6 h, yet deprive the cell of
sufficient metabolic energy to delay apoptotic progression.
Alternatively, SYTO 13 may sterically interfere with the
mechanisms involved in chromosome nicking and chro-
matin condensation, disrupting the morphological appear-
ance of end-stage apoptosis.
Hoechst is a superior alternative to SYTO 13 for reasons
other than the low relative toxicity. SYTO 13 labels cyto-
plasmic RNA as well as nuclear DNA, complicating mea-
surements of nuclear size. Hoechst, on the other hand,
preferentially intercalates between adenine and thymine in
DNA minor grooves, rendering it specific for nuclear
chromatin. Unlike SYTO 13, which had to be applied on
an hourly basis, a single application of Hoechst was suffi-
cient for 6 h, significantly reducing reagent costs and the
potential for cumulative toxicity. Although reducing the
concentration of SYTO 13 decreased the intensity of non-
nuclear fluorescence, the weak nuclear signal made plani-
metric measurements difficult.Conclusions
In a comparative evaluation of the suitability of SYTO
13 and Hoechst for time-lapse imaging studies of neuron
viability and cell death, we found that SYTO 13 was
acutely neurotoxic at high doses within 3 h, whereas
Hoechst-treated neurons remained viable for at least
6 h. In an apoptotic model, 5 and 500 nM SYTO 13
interfered with the ability to distinguish between apop-
totic and necrotic cell death. In contrast, a single admin-
istration of 8 μM Hoechst was sufficient to identify
nuclear condensation by 4 h, without evidence of necro-
sis through 6 h. Neurons are generally sensitive to exter-
nal insults, and thus may be more susceptible to SYTO
13 than other cell lines. Nonetheless, given the evidence
of acute toxicity in SYTO 13-treated cultures, Hoechst is
a superior alternative for short-term, longitudinal evalua-
tions of neuron viability and nuclear morphology.Methods
Embryonic stem cell culture and neuronal differentiation
ESNs were generated, plated and cultured as previously
described [10,11]. ESNs were maintained in NeurobasalW-
A medium (NBA, Life Technologies, Carlsbad, CA) withglutamine, B27 supplement and penicillin/streptomycin
(Sigma-Aldrich, St Louis, MO) at 37°C and 5% CO2.
Morphological evaluation of DNA condensation and
membrane disruption
For longitudinal imaging, DIV 14 ESNs plated on 18 mm
coverslips were transferred to a Zeiss LSM-700 confocal
microscope stage in a constant-temperature environmen-
tal chamber at 37°C and incubated in HibernateW-E,
media supplemented with glutamine, B27 vitamins and
penicillin/streptomycin (Life Technologies), PI (10 μg/mL,
Sigma-Aldrich) and either SYTO 13 (500 nM or 5 nM,
Life Technologies) or Hoechst (5 μg/mL, (Intergen,
Oxford, U.K.) for 10 minutes. After the incubation period,
neurons were perfused with complete HibernateW-E
medium using a Minipuls 3 peristaltic pump (Gilson, Inc)
at 200 μL/minute. After 50 minutes, the pump was turned
off and PI (and SYTO 13, if used) was added to the cover-
slip for 10 minutes. The pump was then restarted and
images were captured at 20x using manufacturer-specified
excitation wavelengths and emission filter sets. These
steps were repeated on an hourly basis for 6 h. For a neur-
onal model of apoptosis, staurosporine (Sigma-Aldrich)
was applied at 1 μM in the perfusion media throughout
the 6 h experiment.
For end-point assays, ESNs on 18-mm coverslips in 12-
well dishes were washed and incubated for 6 h in
complete NBA medium without (control) or with 1 μM
staurosporine. After 6 h, the media was replaced with
complete NBA supplemented with 5 μg/mL PI for 10 min
at 37°C and 5% CO2 followed by complete NBA with
5 μg/mL Hoechst or 500 nM SYTO 13 for 5 min. Cover-
slips were then washed twice with PBS, fixed in 4% paraf-
ormaldehyde in PBS for 20 min, mounted on glass slides
with Prolong Gold antifade reagent and imaged as above.
Planimetric measurements of nuclear area
Twenty nuclei per time point were measured along or-
thogonal axes using Zen 2009 and averaged. The same
nuclei were measured longitudinally from 0–6 h. A simi-
lar measurement methodology was used for end-point
assays, except over 50 nuclei. Average diameters were
converted to areas and graphed with Prism version 5.04
(GraphPad Software). Longitudinal changes in mean nu-
clear sizes were compared using repeated-measures
ANOVA and significances determined with Tukey’s
post-hoc comparison. Student’s t-tests were used to
compare the mean nuclear sizes in end-point assays.
Abbreviations
PI: propidium iodide; ESNs: embryonic stem cell-derived neurons;
Hoechst: Hoechst 32444; NBA: Neurobasal-A medium.
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